Literature DB >> 20175192

Cancer models in Caenorhabditis elegans.

Natalia V Kirienko1, Kumaran Mani, David S Fay.   

Abstract

Although now dogma, the idea that nonvertebrate organisms such as yeast, worms, and flies could inform, and in some cases even revolutionize, our understanding of oncogenesis in humans was not immediately obvious. Aided by the conservative nature of evolution and the persistence of a cohort of devoted researchers, the role of model organisms as a key tool in solving the cancer problem has, however, become widely accepted. In this review, we focus on the nematode Caenorhabditis elegans and its diverse and sometimes surprising contributions to our understanding of the tumorigenic process. Specifically, we discuss findings in the worm that address a well-defined set of processes known to be deregulated in cancer cells including cell cycle progression, growth factor signaling, terminal differentiation, apoptosis, the maintenance of genome stability, and developmental mechanisms relevant to invasion and metastasis. Copyright (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20175192      PMCID: PMC4098942          DOI: 10.1002/dvdy.22247

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  572 in total

Review 1.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

2.  C. elegans mre-11 is required for meiotic recombination and DNA repair but is dispensable for the meiotic G(2) DNA damage checkpoint.

Authors:  G M Chin; A M Villeneuve
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

Review 3.  Involvement of RB gene family in tumor angiogenesis.

Authors:  C Gabellini; D Del Bufalo; G Zupi
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

4.  A beta-catenin identified by functional rather than sequence criteria and its role in Wnt/MAPK signaling.

Authors:  Ambrose R Kidd; Jennifer A Miskowski; Kellee R Siegfried; Hitoshi Sawa; Judith Kimble
Journal:  Cell       Date:  2005-06-03       Impact factor: 41.582

Review 5.  Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation.

Authors:  Chanan Rubin; Gal Gur; Yosef Yarden
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

6.  METT-10, a putative methyltransferase, inhibits germ cell proliferative fate in Caenorhabditis elegans.

Authors:  Maia Dorsett; Bethany Westlund; Tim Schedl
Journal:  Genetics       Date:  2009-07-13       Impact factor: 4.562

7.  Translational repression of cyclin E prevents precocious mitosis and embryonic gene activation during C. elegans meiosis.

Authors:  Bjoern Biedermann; Jane Wright; Mathias Senften; Irene Kalchhauser; Gautham Sarathy; Min-Ho Lee; Rafal Ciosk
Journal:  Dev Cell       Date:  2009-09       Impact factor: 12.270

Review 8.  Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation.

Authors:  Garth L Nicolson; Akihiro Nawa; Yasushi Toh; Shigeki Taniguchi; Katsuhiko Nishimori; Amr Moustafa
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  sli-1, a negative regulator of let-23-mediated signaling in C. elegans.

Authors:  G D Jongeward; T R Clandinin; P W Sternberg
Journal:  Genetics       Date:  1995-04       Impact factor: 4.562

10.  Mutations in cye-1, a Caenorhabditis elegans cyclin E homolog, reveal coordination between cell-cycle control and vulval development.

Authors:  D S Fay; M Han
Journal:  Development       Date:  2000-09       Impact factor: 6.868

View more
  29 in total

Review 1.  Developmental decisions: balancing genetics and the environment by C. elegans.

Authors:  David V Tobin; Richard Mako Saito
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

2.  Control of Cdc14 activity coordinates cell cycle and development in Caenorhabditis elegans.

Authors:  Sarah H Roy; Joseph E Clayton; Jenna Holmen; Eleanor Beltz; R Mako Saito
Journal:  Mech Dev       Date:  2011-06-24       Impact factor: 1.882

Review 3.  From phenologs to silent suppressors: Identifying potential therapeutic targets for human disease.

Authors:  Andy Golden
Journal:  Mol Reprod Dev       Date:  2017-10-03       Impact factor: 2.609

Review 4.  Dissection of genetic pathways in C. elegans.

Authors:  Zheng Wang; David R Sherwood
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

Review 5.  Role of Astrocytes in Manganese Neurotoxicity Revisited.

Authors:  Tao Ke; Marta Sidoryk-Wegrzynowicz; Edward Pajarillo; Asha Rizor; Félix Alexandre Antunes Soares; Eunsook Lee; Michael Aschner
Journal:  Neurochem Res       Date:  2019-09-30       Impact factor: 3.996

6.  Caenorhabditis elegans as a platform to study the mechanism of action of synthetic antitumor lipids.

Authors:  Adolfo Sánchez-Blanco; Alberto G Rodríguez-Matellán; Mariana Reis-Sobreiro; Beatriz Sáenz-Narciso; Juan Cabello; William A Mohler; Faustino Mollinedo
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Determination of reliable reference genes for multi-generational gene expression analysis on C. elegans exposed to abused drug nicotine.

Authors:  Faten A Taki; Baohong Zhang
Journal:  Psychopharmacology (Berl)       Date:  2013-05-17       Impact factor: 4.530

Review 8.  Worms, bacteria, and micronutrients: an elegant model of our diet.

Authors:  Lutfu Safak Yilmaz; Albertha J M Walhout
Journal:  Trends Genet       Date:  2014-08-26       Impact factor: 11.639

9.  Danio rerio: Small Fish Making a Big Splash in Leukemia.

Authors:  Barbara Squiban; J Kimble Frazer
Journal:  Curr Pathobiol Rep       Date:  2014-06

Review 10.  Animal Models to Study MicroRNA Function.

Authors:  Arpita S Pal; Andrea L Kasinski
Journal:  Adv Cancer Res       Date:  2017-08-08       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.